Hey Derrickcan...I believe you have it mixed up with milestone payments. As far as I know the $120 million milestone payments in total would have come from Viopharma, if and when their drug were to receive approval from the fda for FA. I don't believe anyone knows the structure of the pfzier deal for Ponzeumab, and Pfzier is doing everything in their power not to pay or give any credit to Intellect for it. I still believe we are going to see a buyout here within the next few months for anywhere between .025 to .05. GLTA